rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1995-3-3
|
pubmed:abstractText |
The purpose of this study was to compare, within a randomized controlled trial, the efficacy of recombinant interferon-alpha in combination with ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic HCV hepatitis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0002-9270
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
263-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7847298-Adult,
pubmed-meshheading:7847298-Chronic Disease,
pubmed-meshheading:7847298-Drug Therapy, Combination,
pubmed-meshheading:7847298-Female,
pubmed-meshheading:7847298-Follow-Up Studies,
pubmed-meshheading:7847298-Hepatitis C,
pubmed-meshheading:7847298-Humans,
pubmed-meshheading:7847298-Interferon-alpha,
pubmed-meshheading:7847298-Male,
pubmed-meshheading:7847298-Middle Aged,
pubmed-meshheading:7847298-Probability,
pubmed-meshheading:7847298-Recombinant Proteins,
pubmed-meshheading:7847298-Recurrence,
pubmed-meshheading:7847298-Regression Analysis,
pubmed-meshheading:7847298-Treatment Outcome,
pubmed-meshheading:7847298-Ursodeoxycholic Acid
|
pubmed:year |
1995
|
pubmed:articleTitle |
Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
|
pubmed:affiliation |
2nd Gastroenterology Division, University La Sapienza, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|